 |
The Journal of Neuroscience, July 30, 2003, 23(17):6788-6792
Previous Article | Next Article 
BRIEF COMMUNICATION
App Gene Dosage Modulates Endosomal Abnormalities of Alzheimer's Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome
Anne M. Cataldo,1,2,3
Suzana Petanceska,3
Corrinne M. Peterhoff,3
Nicole B. Terio,3
Charles J. Epstein,4
Angela Villar,4
Elaine J. Carlson,5
Matthias Staufenbiel,6 and
Ralph A. Nixon3,7
1Mailman Research Center, McLean Hospital,
Belmont, Massachusetts 02478, 2Department of
Psychiatry, Harvard Medical School, Boston, Massachusetts 02115,
3Center for Dementia Research, Nathan Kline Institute,
Orangeburg, New York 10962, 4Department of Pediatrics,
University of California, San Francisco, San Francisco, California 94143,
5Genomics Core Facility, University of California, San
Francisco, San Francisco, California 94143, 6Novartis
Institute of Biomedical Research, Nervous System, CH-4002 Basel, Switzerland,
and 7Departments of Psychiatry and Cell Biology, New
York University School of Medicine, New York, New York 10016
Altered neuronal endocytosis is the earliest known pathology in sporadic
Alzheimer's disease (AD) and Down syndrome (DS) brain and has been linked to
increased A production. Here, we show that a genetic model of DS
(trisomy 21), the segmental trisomy 16 mouse Ts65Dn, develops enlarged
neuronal early endosomes, increased immunoreactivity for markers of endosome
fusion (rab5, early endosomal antigen 1, and rabaptin5), and endosome
recycling (rab4) similar to those in AD and DS individuals. These
abnormalities are most prominent in neurons of the basal forebrain, which
later develop aging-related atrophy and degenerative changes, as in AD and DS.
We also show that App, one of the triplicated genes in Ts65Dn mice
and human DS, is critical to the development of these endocytic abnormalities.
Selectively deleting one copy of App or a small portion of the
chromosome 16 segment containing App from Ts65Dn mice eliminated the
endosomal phenotype. Overexpressing App at high levels in mice did
not alter early endosomes, implying that one or more additional genes on the
triplicated segment of chromosome 16 are also required for the Ts65Dn
endosomal phenotype. These results identify an essential role for App
gene triplication in causing AD-related endosomal abnormalities and further
establish the pathogenic significance of endosomal dysfunction in AD.
Key words: endosomes; endocytic pathway; Ts65Dn; Ts1Cje; Down syndrome; Alzheimer's disease; amyloid precursor protein; basal forebrain neurons
Received Apr. 7, 2003;
revised Apr. 7, 2003;
accepted May. 14, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
K. T. Chang and K.-T. Min
Upregulation of three Drosophila homologs of human chromosome 21 genes alters synaptic function: Implications for Down syndrome
PNAS,
October 6, 2009;
106(40):
17117 - 17122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Thomas, B. Ritter, D. Verbich, C. Sanson, L. Bourbonniere, R. A. McKinney, and P. S. McPherson
Intersectin Regulates Dendritic Spine Development and Somatodendritic Endocytosis but Not Synaptic Vesicle Recycling in Hippocampal Neurons
J. Biol. Chem.,
May 1, 2009;
284(18):
12410 - 12419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yu, P.-Y. Chu, D. N. Bowser, D. J. Keating, D. Dubach, I. Harper, J. Tkalcevic, D. I. Finkelstein, and M. A. Pritchard
Mice deficient for the chromosome 21 ortholog Itsn1 exhibit vesicle-trafficking abnormalities
Hum. Mol. Genet.,
November 1, 2008;
17(21):
3281 - 3290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Cataldo, P. M. Mathews, A. B. Boiteau, L. C. Hassinger, C. M. Peterhoff, Y. Jiang, K. Mullaney, R. L. Neve, J. Gruenberg, and R. A. Nixon
Down Syndrome Fibroblast Model of Alzheimer-Related Endosome Pathology: Accelerated Endocytosis Promotes Late Endocytic Defects
Am. J. Pathol.,
August 1, 2008;
173(2):
370 - 384.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. V. Voronov, S. G. Frere, S. Giovedi, E. A. Pollina, C. Borel, H. Zhang, C. Schmidt, E. C. Akeson, M. R. Wenk, L. Cimasoni, et al.
Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome
PNAS,
July 8, 2008;
105(27):
9415 - 9420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Keating, D. Dubach, M. P. Zanin, Y. Yu, K. Martin, Y.-F. Zhao, C. Chen, S. Porta, M. L. Arbones, L. Mittaz, et al.
DSCR1/RCAN1 regulates vesicle exocytosis and fusion pore kinetics: implications for Down syndrome and Alzheimer's disease
Hum. Mol. Genet.,
April 1, 2008;
17(7):
1020 - 1030.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Schneider, L. Rajendran, M. Honsho, M. Gralle, G. Donnert, F. Wouters, S. W. Hell, and M. Simons
Flotillin-Dependent Clustering of the Amyloid Precursor Protein Regulates Its Endocytosis and Amyloidogenic Processing in Neurons
J. Neurosci.,
March 12, 2008;
28(11):
2874 - 2882.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-R. Ryoo, H. K. Jeong, C. Radnaabazar, J.-J. Yoo, H.-J. Cho, H.-W. Lee, I.-S. Kim, Y.-H. Cheon, Y. S. Ahn, S.-H. Chung, et al.
DYRK1A-mediated Hyperphosphorylation of Tau: A FUNCTIONAL LINK BETWEEN DOWN SYNDROME AND ALZHEIMER DISEASE
J. Biol. Chem.,
November 30, 2007;
282(48):
34850 - 34857.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Tate and P. M. Mathews
Targeting the Role of the Endosome in the Pathophysiology of Alzheimer's Disease: A Strategy for Treatment
Sci. Aging Knowl. Environ.,
June 28, 2006;
2006(10):
re2 - re2.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zhang, A. Haapasalo, D. Y. Kim, L. A. M. Ingano, W. H. Pettingell, and D. M. Kovacs
Presenilin/{gamma}-secretase activity regulates protein clearance from the endocytic recycling compartment
FASEB J,
June 1, 2006;
20(8):
1176 - 1178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Langui, N. Girardot, K. H. El Hachimi, B. Allinquant, V. Blanchard, L. Pradier, and C. Duyckaerts
Subcellular Topography of Neuronal A{beta} Peptide in APPxPS1 Transgenic Mice
Am. J. Pathol.,
November 1, 2004;
165(5):
1465 - 1477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Nixon
Niemann-Pick Type C Disease and Alzheimer's Disease: The APP-Endosome Connection Fattens Up
Am. J. Pathol.,
March 1, 2004;
164(3):
757 - 761.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|